Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.04.2021 | Case report

Pembrolizumab

Gastritis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Okubo Y, et al. Gastrointestinal: Recurrence of pembrolizumab-induced severe gastritis after tapering steroid therapy. Journal of Gastroenterology and Hepatology 36: 586, No. 3, Mar 2021. Available from: URL: http://doi.org/10.1111/jgh.15248 Okubo Y, et al. Gastrointestinal: Recurrence of pembrolizumab-induced severe gastritis after tapering steroid therapy. Journal of Gastroenterology and Hepatology 36: 586, No. 3, Mar 2021. Available from: URL: http://​doi.​org/​10.​1111/​jgh.​15248
Metadaten
Titel
Pembrolizumab
Gastritis: case report
Publikationsdatum
01.04.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-94375-0

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Adalimumab

Case report

Multiple drugs

Case report

Methotrexate